Skip to content
Screener

Eton Pharmaceuticals, Inc. ETON Ratios & Valuation

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
Profitability
Gross margin57.9%-1.5pp54.8%-3.7pp53.5%-6.6pp51.4%-7.9pp59.4%-0.1pp
Efficiency
Asset turnover1×+0.1×1×+0.1×1×+0.2×1×0.0×0.9×-0.1×
Liquidity
Current ratio1.5×-0.3×1.2×-0.8×1.6×-0.5×1.6×+0.1×1.8×+0.4×
Leverage
Debt-to-equity0.6×-0.7×1×-0.2×1.2×0.0×1.3×+1.1×1.3×+0.9×
Per Share
Book value per share$1.42+59.5%$0.97+6.7%——$0.86+42.9%$0.89+70.6%
Valuation
Market capitalization$1.49B+180%$673.38M+93.4%$453.48M+30.7%$582.75M+276%$364.45M+331%
Price / sales14.1×+6.5×7.7×+0.5×5.7×-3.2×8.3×+3.8×6.3×+3.6×
Price / book31.9×+8.9×22×+7.8×17.3×+3.1×25.2×+15.5×15.2×+8.9×

FAQ

What are Eton Pharmaceuticals, Inc.'s profit margins?
Eton Pharmaceuticals, Inc. (ETON) runs a 57.9% gross margin and a -15.1% operating margin, with a -9.5% net margin.
Where do Eton Pharmaceuticals, Inc.'s ratios come from?
Every ratio is computed from Eton Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.